Royal Bank of Canada’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-29,645
Closed -$13K 7173
2015
Q3
$13K Buy
29,645
+3,883
+15% +$2.22K ﹤0.01% 5790
2015
Q2
$13K Sell
25,762
-13,041
-34% -$8.86K ﹤0.01% 5962
2015
Q1
$28K Buy
38,803
+8,237
+27% +$5.29K ﹤0.01% 5218
2014
Q4
$16K Buy
30,566
+2,791
+10% +$1.69K ﹤0.01% 5475
2014
Q3
$16K Buy
27,775
+10,433
+60% +$13.2K ﹤0.01% 5357
2014
Q2
$23K Buy
17,342
+526
+3% +$754 ﹤0.01% 5159
2014
Q1
$30K Buy
16,816
+3,979
+31% +$6.72K ﹤0.01% 5059
2013
Q4
$19K Sell
12,837
-48,944
-79% -$110K ﹤0.01% 5284
2013
Q3
$150K Buy
61,781
+51,101
+478% +$141K ﹤0.01% 4254
2013
Q2
$30K Buy
+10,680
New +$29.5K ﹤0.01% 4893

Other funds holding ONCY

Royal Bank of Canada's ONCY Position: Q4 2015 in Review

Royal Bank of Canada sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q4 2015, closing a stake of 29,645 shares — an estimated $13K sold.

Royal Bank of Canada first reported a position in ONCY in Q2 2013 and held it in 10 quarters. The position peaked at $150K in Q3 2013. 7 funds tracked by Wall St. Rank hold ONCY as of Q4 2015.

  • Royal Bank of Canada reported no remaining ONCOLYTICS BIOTECH INC position as of Q4 2015 after selling out during the quarter.
  • Royal Bank of Canada sold 29,645 ONCOLYTICS BIOTECH INC shares in Q4 2015, an estimated $13K.
  • Royal Bank of Canada first reported a position in ONCOLYTICS BIOTECH INC in Q2 2013 and held it in 10 quarters.
  • Royal Bank of Canada's ONCOLYTICS BIOTECH INC position peaked at $150K in Q3 2013.
  • 7 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q4 2015.

Based on Royal Bank of Canada's 13F filing for Q4 2015, filed 16 Feb 2016.